Literature DB >> 22567190

Potent and sustained cellular inhibition of miR-122 by lysine-derivatized peptide nucleic acids (PNA) and phosphorothioate locked nucleic acid (LNA)/2'-O-methyl (OMe) mixmer anti-miRs in the absence of transfection agents.

Adrian G Torres1, Richard N Threlfall, Michael J Gait.   

Abstract

Efficient cell delivery of antisense oligonucleotides (ONs) is a key issue for their potential therapeutic use. It has been shown recently that some ONs can be delivered into cells without the use of transfection agents (gymnosis), but this generally requires cell incubation over several days and high amounts of ONs (micromolar concentrations). Here we have targeted microRNA 122 (miR-122), a small non-coding RNA involved in regulation of lipid metabolism and in the replication of hepatitis C virus, with ONs of different chemistries (anti-miRs) by gymnotic delivery in cell culture. Using a sensitive dual-luciferase reporter assay, anti-miRs were screened for their ability to enter liver cells gymnotically and inhibit miR-122 activity. Efficient miR-122 inhibition was obtained with cationic PNAs and 2'-O-methyl (OMe) and Locked Nucleic Acids (LNA)/OMe mixmers containing either phosphodiester (PO) or phosphorothioate (PS) linkages at sub-micromolar concentrations when incubated with cells for just 4 hours. Furthermore, PNA and PS-containing anti-miRs were able to sustain miR-122 inhibitory effects for at least 4 days. LNA/OMe PS anti-miRs were the most potent anti-miR chemistry tested in this study, an ON chemistry that has been little exploited so far as anti-miR agents towards therapeutics.

Entities:  

Keywords:  2’-O-Methyl; Gymnosis; Locked Nucleic Acids; Peptide Nucleic Acids; anti-miR; delivery; miR-122; miRNA; phosphorothioate; transfection

Mesh:

Substances:

Year:  2011        PMID: 22567190      PMCID: PMC3324337          DOI: 10.4161/adna.17731

Source DB:  PubMed          Journal:  Artif DNA PNA XNA        ISSN: 1949-095X


  50 in total

Review 1.  Control of RNA silencing and localization by endolysosomes.

Authors:  Derrick Gibbings; Olivier Voinnet
Journal:  Trends Cell Biol       Date:  2010-07-13       Impact factor: 20.808

Review 2.  microRNA functions.

Authors:  Natascha Bushati; Stephen M Cohen
Journal:  Annu Rev Cell Dev Biol       Date:  2007       Impact factor: 13.827

3.  A highly effective and long-lasting inhibition of miRNAs with PNA-based antisense oligonucleotides.

Authors:  Su Young Oh; YeongSoon Ju; Heekyung Park
Journal:  Mol Cells       Date:  2009-09-30       Impact factor: 5.034

4.  Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides.

Authors:  A Arzumanov; A P Walsh; V K Rajwanshi; R Kumar; J Wengel; M J Gait
Journal:  Biochemistry       Date:  2001-12-04       Impact factor: 3.162

5.  Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development.

Authors:  Hui Xu; Jie-Hua He; Zhen-Dong Xiao; Qian-Qian Zhang; Yue-Qin Chen; Hui Zhou; Liang-Hu Qu
Journal:  Hepatology       Date:  2010-10       Impact factor: 17.425

6.  Efficient inhibition of miR-155 function in vivo by peptide nucleic acids.

Authors:  Martin M Fabani; Cei Abreu-Goodger; Donna Williams; Paul A Lyons; Adrian G Torres; Kenneth G C Smith; Anton J Enright; Michael J Gait; Elena Vigorito
Journal:  Nucleic Acids Res       Date:  2010-03-11       Impact factor: 16.971

7.  Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome.

Authors:  Catherine L Jopling; Sylvia Schütz; Peter Sarnow
Journal:  Cell Host Microbe       Date:  2008-07-17       Impact factor: 21.023

8.  Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfection.

Authors:  Y Zhang; Z Qu; S Kim; V Shi; B Liao; P Kraft; R Bandaru; Y Wu; L M Greenberger; I D Horak
Journal:  Gene Ther       Date:  2010-12-23       Impact factor: 5.250

9.  The apical submembrane cytoskeleton participates in the organization of the apical pole in epithelial cells.

Authors:  P J Salas; M L Rodriguez; A L Viciana; D E Vega-Salas; H P Hauri
Journal:  J Cell Biol       Date:  1997-04-21       Impact factor: 10.539

10.  Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents.

Authors:  C A Stein; J Bo Hansen; Johnathan Lai; SiJian Wu; Anatoliy Voskresenskiy; Anja Høg; Jesper Worm; Maj Hedtjärn; Naira Souleimanian; Paul Miller; Harris S Soifer; Daniella Castanotto; Luba Benimetskaya; Henrik Ørum; Troels Koch
Journal:  Nucleic Acids Res       Date:  2009-10-23       Impact factor: 16.971

View more
  12 in total

Review 1.  Nanotechnology for delivery of peptide nucleic acids (PNAs).

Authors:  Anisha Gupta; Raman Bahal; Meera Gupta; Peter M Glazer; W Mark Saltzman
Journal:  J Control Release       Date:  2016-01-08       Impact factor: 9.776

2.  Inhibition of miR-155 Limits Neuroinflammation and Improves Functional Recovery After Experimental Traumatic Brain Injury in Mice.

Authors:  David J Loane; Alan I Faden; Rebecca J Henry; Sarah J Doran; James P Barrett; Victoria E Meadows; Boris Sabirzhanov; Bogdan A Stoica
Journal:  Neurotherapeutics       Date:  2019-01       Impact factor: 7.620

3.  Cellular uptakes, biostabilities and anti-miR-210 activities of chiral arginine-PNAs in leukaemic K562 cells.

Authors:  Alex Manicardi; Enrica Fabbri; Tullia Tedeschi; Stefano Sforza; Nicoletta Bianchi; Eleonora Brognara; Roberto Gambari; Rosangela Marchelli; Roberto Corradini
Journal:  Chembiochem       Date:  2012-05-25       Impact factor: 3.164

4.  Chemical structure requirements and cellular targeting of microRNA-122 by peptide nucleic acids anti-miRs.

Authors:  Adrian G Torres; Martin M Fabani; Elena Vigorito; Donna Williams; Naowras Al-Obaidi; Filip Wojciechowski; Robert H E Hudson; Oliver Seitz; Michael J Gait
Journal:  Nucleic Acids Res       Date:  2011-11-08       Impact factor: 16.971

5.  CTG repeat-targeting oligonucleotides for down-regulating Huntingtin expression.

Authors:  Eman M Zaghloul; Olof Gissberg; Pedro M D Moreno; Lee Siggens; Mattias Hällbrink; Anna S Jørgensen; Karl Ekwall; Rula Zain; Jesper Wengel; Karin E Lundin; C I Edvard Smith
Journal:  Nucleic Acids Res       Date:  2017-05-19       Impact factor: 16.971

6.  Internalization of Locked Nucleic Acids/DNA Hybrid Oligomers into Escherichia coli.

Authors:  German M Traglia; Carol Davies Sala; Juan I Fuxman Bass; Alfonso J C Soler-Bistué; Angeles Zorreguieta; María Soledad Ramírez; Marcelo E Tolmasky
Journal:  Biores Open Access       Date:  2012-10

7.  Inhibition of cell division induced by external guide sequences (EGS Technology) targeting ftsZ.

Authors:  Carol Davies Sala; Alfonso J C Soler-Bistué; Leeann Korprapun; Angeles Zorreguieta; Marcelo E Tolmasky
Journal:  PLoS One       Date:  2012-10-23       Impact factor: 3.240

Review 8.  Splicing therapy for neuromuscular disease.

Authors:  Andrew G L Douglas; Matthew J A Wood
Journal:  Mol Cell Neurosci       Date:  2013-04-28       Impact factor: 4.314

9.  RNAi2013: RNAi at Oxford.

Authors:  Laura A Mulcahy; David Rf Carter
Journal:  J RNAi Gene Silencing       Date:  2013-05-20

10.  Delivery of cell-penetrating peptide-peptide nucleic acid conjugates by assembly on an oligonucleotide scaffold.

Authors:  Xing-Liang Zhao; Bi-Cheng Chen; Jin-Chao Han; Lai Wei; Xiao-Ben Pan
Journal:  Sci Rep       Date:  2015-11-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.